Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa observer-blind randomized study of adjuvanted quadrivalent influenza vaccine formulations in children 6-35 months old
2010-020312-12Phase 2Terminated
- Sponsor
- GSK
- Start
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Influenza vaccine (adjuvanted quadrivalent, GSK2584786A) and Fluarix in influenza (4 arms), sponsored by GSK. Primary endpoints: Hemagglutination inhibition antibody geometric mean titers, Neutralizing antibody geometric mean titers and 2 more. Started Jul 2010; status: terminated.
02
Drugs
Influenza vaccine (adjuvanted quadrivalent, GSK2584786A)Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-020312-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020312-12.